These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1435349)

  • 1. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia.
    al-Ssum RM
    Microbiologica; 1992 Oct; 15(4):355-9. PubMed ID: 1435349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL; Stone RM; Iglewski BH; Pennington JE
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
    Ogaard AR; Cryz SJ; Berdal BP
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):217-23. PubMed ID: 3929560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
    Sharma S; Kaur R; Yadav V; Harjai K; Joshi K
    Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes.
    Staugas RE; Harvey DP; Ferrante A; Nandoskar M; Allison AC
    Infect Immun; 1992 Aug; 60(8):3162-8. PubMed ID: 1639487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa extracellular toxicity in infant mice and the protective effect of antitoxin A.
    Ogaard AR; Berdal BP
    APMIS; 1989 May; 97(5):475-8. PubMed ID: 2499347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
    Cash HA; Straus DC; Bass JA
    Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.
    Taylor NS; Pollack M
    Infect Immun; 1978 Jan; 19(1):66-70. PubMed ID: 415008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation of Pseudomonas aeruginosa exotoxin A by affinity chromatography using specific antibodies].
    Vovk VA; Uchakina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):64-8. PubMed ID: 2500003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M
    Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
    Sarac MS; Cameron A; Lindberg I
    Infect Immun; 2002 Dec; 70(12):7136-9. PubMed ID: 12438396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of exotoxin A from pseudomonas aeruginosa.
    Collier RJ; McKay DB
    J Mol Biol; 1982 May; 157(2):413-5. PubMed ID: 6809953
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.